IBO
Impact BioMedical Inc
3월 13일 3:58 PM ET (한국 3/14 04:58)
$0.46
-0.10 ▼ -18.73%
🌙 3월 13일 7:56 PM ET (한국 3/14 08:56)
$0.47
+0.01 ▲ +2.99%
| Index | - | P/E | - | EPS (ttm) | -1.35 | Insider Own | 0.09% | Shs Outstand | 0.10B | Perf Week | -32.3% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | - | Insider Trans | -63.1% | Shs Float | 0.10B | Perf Month | -5.17% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | - | Inst Own | 1.38% | Short Float | 0.15% | Perf Quarter | -8.96% |
| Income | -0.01B | P/S | 1587.43 | EPS this Y | - | Inst Trans | 0.97% | Short Ratio | 0.03 | Perf Half Y | -30.54% |
| Sales | 0.00B | P/B | 3.78 | EPS next 5Y | - | ROA | -54.9% | Short Interest | 0.15M | Perf YTD | -9.86% |
| Book/sh | 0.12 | P/C | - | EPS past 3/5Y | 15.09% -48.53% | ROE | -140.36% | 52W High | -92.62% ($6.17) | Perf Year | -32.08% |
| Cash/sh | 0 | P/FCF | - | Sales past 3/5Y | - | ROIC | -93.89% | 52W Low | 25.71% ($0.36) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 37.36% | Gross Margin | -4834.38% | Volatility(W/M) | 11.96% 13.05% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1685.77 | Sales Y/Y TTM | - | Oper. Margin | -13340.62% | ATR (14) | 0.07 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.3 | EPS Q/Q | 102.13% | Profit Margin | -36993.75% | RSI (14) | 44.93 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.35 | Sales Q/Q | - | SMA20 | -6.29% ($0.49) | Beta | 5.02 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -6.14% ($0.49) | Rel Volume | 0.12 | Prev Close | $0.56 |
| Employees | 8 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -18.51% ($0.56) | Avg Volume(3M) | 4.35M | Price | $0.46 |
| IPO | 2024/9/16 | Option/Short | No/Yes | Trades | 1066 | Volume | 517,386 | Change | -18.73% |
뉴스 로딩 중...